Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harry Hollema

Showing results (1-10 of 131) with videos related to

Pageof 14
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 6, 2011
Letter commenting on "risk-reducing salpingo-oophorectomy (RRSO) in BRCA mutation carriers: experience with a consecutive series of 111 patients using a standardized surgical-pathological protocol" in Int J Gynecol Cancer 2011;21: 846-851 by C. Bethan Powell et alWelmoed Reitsma, Harry Hollema, Marian J E Mourits
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2015
Pathologic findings at risk-reducing surgeryMarian J Mourits, Geertruida H de Bock, Harry Hollema
Cancer|May 10, 2002
Expression of estrogen receptor, progesterone receptor, and insulin-like growth factor receptor-1 and of MIB-1 in patients with recurrent pleomorphic adenoma of the parotid glandAfina S Glas, Harry Hollema, Raoul E Nap, et al.
Cancer Letters|June 28, 2005
Prognostic role of cyclooxygenase-2 expression in esophageal carcinomaPierre Heeren, John Plukker, Hendrik van Dullemen, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 20, 2012
Endometrium is not the primary site of origin of pelvic high-grade serous carcinoma in BRCA1 or BRCA2 mutation carriersWelmoed Reitsma, Marian J E Mourits, Geertruida H de Bock, et al.
Familial Cancer|October 28, 2016
Pain evaluation during gynaecological surveillance in women with Lynch syndromeJorien Helder-Woolderink, Geertruida de Bock, Harry Hollema, et al.
The American Journal of Gastroenterology|October 24, 2003
Hyperplastic polyps in hereditary nonpolyposis colorectal cancerFleur E M Rijcken, Tineke van der Sluis, Harry Hollema, et al.
Breast Cancer Research and Treatment|January 20, 2018
Digital image analysis of Ki67 proliferation index in breast cancer using virtual dual staining on whole tissue sections: clinical validation and inter-platform agreementTimco Koopman, Henk J Buikema, Harry Hollema, et al.
Histopathology|December 27, 2018
What is the added value of digital image analysis of HER2 immunohistochemistry in breast cancer in clinical practice? A study with multiple platformsTimco Koopman, Henk J Buikema, Harry Hollema, et al.
Gynecologic Oncology|April 22, 2004
Letter commenting on "Patholologic finding in prophylactic oophorectomy specimens in high-risk women" (87:52-6) by Pamela Paley, et al. (, fax: +31-206-685-9607)Marian J E Mourits, Joanne A De Hullu, Ate G J Van Der Zee, et al.
Pageof 14

Showing results (1-10 of 131) with videos related to

Sort By:
Pageof 14
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 6, 2011
Letter commenting on "risk-reducing salpingo-oophorectomy (RRSO) in BRCA mutation carriers: experience with a consecutive series of 111 patients using a standardized surgical-pathological protocol" in Int J Gynecol Cancer 2011;21: 846-851 by C. Bethan Powell et alWelmoed Reitsma, Harry Hollema, Marian J E Mourits
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2015
Pathologic findings at risk-reducing surgeryMarian J Mourits, Geertruida H de Bock, Harry Hollema
Cancer|May 10, 2002
Expression of estrogen receptor, progesterone receptor, and insulin-like growth factor receptor-1 and of MIB-1 in patients with recurrent pleomorphic adenoma of the parotid glandAfina S Glas, Harry Hollema, Raoul E Nap, et al.
Cancer Letters|June 28, 2005
Prognostic role of cyclooxygenase-2 expression in esophageal carcinomaPierre Heeren, John Plukker, Hendrik van Dullemen, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 20, 2012
Endometrium is not the primary site of origin of pelvic high-grade serous carcinoma in BRCA1 or BRCA2 mutation carriersWelmoed Reitsma, Marian J E Mourits, Geertruida H de Bock, et al.
Familial Cancer|October 28, 2016
Pain evaluation during gynaecological surveillance in women with Lynch syndromeJorien Helder-Woolderink, Geertruida de Bock, Harry Hollema, et al.
The American Journal of Gastroenterology|October 24, 2003
Hyperplastic polyps in hereditary nonpolyposis colorectal cancerFleur E M Rijcken, Tineke van der Sluis, Harry Hollema, et al.
Breast Cancer Research and Treatment|January 20, 2018
Digital image analysis of Ki67 proliferation index in breast cancer using virtual dual staining on whole tissue sections: clinical validation and inter-platform agreementTimco Koopman, Henk J Buikema, Harry Hollema, et al.
Histopathology|December 27, 2018
What is the added value of digital image analysis of HER2 immunohistochemistry in breast cancer in clinical practice? A study with multiple platformsTimco Koopman, Henk J Buikema, Harry Hollema, et al.
Gynecologic Oncology|April 22, 2004
Letter commenting on "Patholologic finding in prophylactic oophorectomy specimens in high-risk women" (87:52-6) by Pamela Paley, et al. (, fax: +31-206-685-9607)Marian J E Mourits, Joanne A De Hullu, Ate G J Van Der Zee, et al.
Pageof 14